Michael Falvey
Executive Vice President
Veterinary Sciences
Karyopharm Therapeutics
United States of America
Biography
Mr. Falvey brings to Karyopharm 35 years of experience in executing business growth and financial strategies for publicly-traded and privately-held companies, including senior financial leadership roles at healthcare-focused, scientific organizations. Prior to joining Karyopharm, he served as Chief Financial Officer at several high-growth, revenue-generating companies, including Seven Bridges Genomics, Analysis Group, Ahura Scientific and Aspect Medical Systems.
Research Interest
Veterinary Sciences